Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a precision cell immunotherapy combined with transcatheter arterial chemoembolization (TACE) for advanced liver cancer; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Precision Cell Immunotherapy

Snippet

Sponsor: Ningbo Cancer Hospital | Conditions: Precision Cell Immunotherapy, Transcatheter Arterial Chemoembolization | Phase 1, Phase 2 | Status: UNKNOWN